Document:

Series B-1 Preferred Stock Warrant of the Registrant

 EXHIBIT 4.4 
 NEITHER THIS WARRANT (THE “WARRANT”) NOR THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO SALE, TRANSFER OR OTHER DISPOSITION OF THIS
WARRANT OR SAID SHARES MAY BE EFFECTED WITHOUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR (ii) AN OPINION OF COUNSEL FOR THE HOLDER, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED, EXCEPT
THAT NO SUCH OPINION SHALL BE REQUIRED IF SUCH SALE IS PURSUANT TO RULE 144 PROMULGATED UNDER THE ACT. 
 WARRANT 
 TO PURCHASE 
 SHARES OF
SERIES B-1 PREFERRED STOCK 
 THIS CERTIFIES THAT, for good and valuable consideration received from Heller Financial Leasing,
Inc. (“Warrantholder”), Warrantholder is entitled to subscribe for and purchase 68,512 of Preferred shares (as adjusted pursuant to provisions hereof, the “Shares”) of the fully paid and non-assessable Series
B-1 Preferred Stock (the “Preferred Stock”) of Danger, Inc., a Delaware corporation with its principal place of business at 124 University Avenue, Palo Alto, CA 94301 (the “Company”), at an exercise price per share
as determined pursuant to Section 1 hereof (such price and such other price as shall result, from time to time, from adjustments specified herein, is hereafter referred to as the “Exercise Price”), subject to the provisions and
upon the terms and conditions hereinafter set forth. As used herein, the term “Preferred Stock” shall mean the Company’s presently authorized Series B-1 Preferred Stock, and any stock into or for which such Series B-1
Preferred Stock may hereafter be converted or exchanged pursuant to the Certificate of Incorporation of the Company as from time to time amended as provided by law and in such Certificate. As used herein, the term “Grant Date”
shall mean January 25, 2002. The Company acknowledges that the cash consideration paid by Warrantholder for this Warrant is $10.00 for income tax purposes, and that this Warrant is issued in connection with that certain financial
accommodation entered into by and between Company as the obligor and Warrantholder as the obligee thereunder (the “Financing Arrangement”). 
 In the event that all of the Preferred Stock is converted into Common Stock, this Warrant shall be exercisable solely for such Common Stock, and any reference throughout this Warrant to shares of Preferred Stock shall
be deemed to refer to the shares of Common Stock into which the Preferred Stock may be converted. 
 1. Term and Exercise Price.

 (a) Term. The purchase rights represented by this Warrant are exercisable, in
whole or in part, at any time and from time to time, from and after the initial occurrence of a Pricing Event (as defined herein) until the seventh (7th) anniversary of the Grant Date. 
  

 1 

 (b) Exercise Price. The Exercise Price may be adjusted from time to time upon the occurrence of
the following events (each such event, a “Pricing Event”): 
 (i) Liquidity Event. If a Liquidity Event (as defined
below) occurs at any time between the Grant Date and July 31, 2002 and an event described in Section 1(b)(ii) or Section 1(b)(iii) has not occurred, the Exercise Price shall equal the sum of $1.4596 per share plus the product of
(a) the difference between (i) the value of the consideration payable in the Liquidity Event on a share of Preferred Stock and (ii) $1.4596, multiplied by (b) the fraction resulting from dividing (i) the number of days
between the Grant Date and the date of the Liquidity Event by (ii) the number of days between July 20, 2001 and the date of the Liquidity Event. “Liquidity Event” shall mean (i) a consolidation or merger of the
Company with or into another corporation or entity (other than a merger with another corporation or entity in which the Company is the surviving corporation and which does not result in any reclassification or change of outstanding securities
issuable upon exercise of this Warrant), (ii) a sale of all or substantially all of the Company’s assets or (iii) a sale of the Company’s Common Stock in a firmly underwritten initial public offering, pursuant to an effective
registration statement under the Act. 
 (ii) Aborted Series B-2 Financing. If a closing of the sale of the Company’s Series B-2
Preferred Stock, at a price per share of $2.5218, does not occur prior to July 31, 2002 (an “Aborted B-2 Financing”), the Exercise Price shall be $1.4596. If at any time following the Aborted B-2 Financing but prior to the expiration
of the Warrant, the Company completes a subsequent bona fide round of equity financing (the “Next Round Financing”), the Exercise Price shall be adjusted to equal the sum of $1.4596 per share plus the product of (a) the
difference between (i) the per share price of the class or series of equity security issued in connection with the Next Round Financing (the “Next Round Stock”) and (ii) $1.4596, multiplied by (b) the fraction
resulting from dividing (i) the number of days between the Grant Date and the date of the Next Round Financing by (ii) the number of days between July 20, 2001 and the date of the Next Round Financing. 
 (iii) Completed Series B-2 Financing. If a closing of the sale of the Company’s Series B-2 Preferred Stock, at a price per share of $2.5218,
occurs prior to July 31, 2002 (a “Completed B-2 Financing”) then the Exercise Price shall be $2.5218. If at any time following the Completed B-2 Financing but prior to the expiration of the Warrant, the Company completes a Next
Round Financing, the Exercise Price shall be adjusted to equal the sum of $2.5218 per share plus the product of (a) the difference between (i) the per share price of the class or series of equity security issued in connection with the Next
Round Financing (the “Next Round Stock”) and (ii) $2.5218, multiplied by (b) the fraction resulting from dividing (i) the number of days between the Grant Date and the date of the Next Round Financing by (ii) the
number of days between July 31, 2002 and the date of the Next Round Financing. 
 2. Method of Exercise; Net Issue Exercise.

 2.1 Method of Exercise; Payment; Issuance of New Warrant. The purchase rights represented by this Warrant may be exercised by the
Warrantholder, in whole or in part and from time to time, by the surrender of this Warrant (with the notice of exercise form attached hereto as 

  

 2 

 
Exhibit A duly executed) at the principal office of the Company and by the payment to the Company of an amount equal to the then applicable Exercise
Price per share multiplied by the number of Shares then being purchased. The Warrantholder shall be deemed to have become the holder(s) of record of, and shall be treated for all purposes as the record holder(s) of, the Shares represented thereby
(and such Shares shall be deemed to have been issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any exercise of the rights represented by this Warrant, certificates for the
Shares so purchased shall be promptly delivered to the holder hereof as soon as practicable (and in any event within 20 business days of receipt of such notice) and, unless this Warrant has been fully exercised or expired, a new Warrant representing
the portion of the Shares, if any, with respect to which this Warrant may thereafter be exercised shall also be issued to the holder hereof as soon as practicable (and in any event within such 20 business day period). 
 2.2 Non-Cash Exercise. 
 (a) In lieu
of payment in cash, the rights represented by this Warrant may also be exercised by a written notice of exercise in the form of Annex A attached hereto, providing for the non-cash exercise of this Warrant for the Shares equal to the value (as
determined below) of this Warrant (or the portion thereof being exercised), specifying that this non-cash exercise election has been made, and the net number of Shares to be issued after giving effect to such non-cash exercise. In the event the
Warrantholder makes such election, Company shall issue to the holder a number of shares computed using the following formula: 
  

					
	X	 	=	 	Y (A – B)
	 	 	       A

 Where: 
  

					
	X	 	=	 	the number of Shares to be issued to the holder
	Y	 	=	 	the number of Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised (as of the date of such non-cash exercise)

	A	 	=	 	the Fair Market Value of one Share of Preferred Stock (as of the date of such non-cash exercise)
	B	 	=	 	Exercise Price of one Share of Preferred Stock (as adjusted to the date of such non-cash exercise)

 (b) For purposes of this Section 2.2, the “Fair Market Value” of one share
of the Company’s Preferred Stock shall be equal to the number of shares of Common Stock into which each share of Preferred Stock is convertible as of the date of the exercise, multiplied by the “Fair Market Value” of a share of Common
Stock (as determined pursuant to this Section 2.2). The “Fair Market Value” of one share of the Company’s Common Stock shall be equal to either (i) if the exercise of this Warrant occurs in connection with an initial public
offering of the Company, the “initial price to public” specified in the final prospectus with respect to the initial public offering and if the Company’s registration statement has been declared effective by the Securities and
Exchange Commission (as provided in Section 2.5), or (ii) if the exercise of this Warrant 

  

 3 

 
occurs after or not in connection with an initial public offering of the Company, the average of the closing price(s) of the Company’s Common Stock as
quoted over the counter or on any exchange on which the Common Stock is listed as such closing prices are published in The Wall Street Journal for the fifteen trading days (or such lesser number of trading days as the stock may have been
actually trading) ending on the day prior to the date of determination of Fair Market Value. Notwithstanding the foregoing, if the Warrant is exercised in connection with a merger or sale of all or substantially all of the Company’s assets,
“Fair Market Value” shall mean the value that would have been allocable to or received in respect of a Warrant Share had the Warrant been exercised immediately prior to such merger or sale. If the Common Stock is not traded
Over-The-Counter or on an exchange, or if the Warrant is not exercised in connection with a merger or sale of all or substantially all of its assets, the Fair Market Value shall be determined in good faith by the Company’s board of directors.
If the holder hereof does not agree with the determination of Fair Market Value as determined by the Company’s board of directors, the Company and the holder hereof shall negotiate an appropriate Fair Market Value. If after ten (10) days,
the Company and the holder cannot agree, then the holder may request that the Fair Market Value be determined by an investment banker of national reputation selected by the Company and reasonably acceptable to the Warrantholder. The fees and
expenses of such investment banker shall be borne by the Company unless the Fair Market Value determined by such investment banker is equal to or less than the Fair Market Value as determined by the Company, in which event the fees and expenses of
such investment banker shall be borne by the holder hereof. 
 2.3 Exercise Into Common Stock. Upon any exercise of this Warrant, at
the election of the holder, this Warrant may be exercised into the number of shares of Common Stock into which the Shares issuable upon such exercise are then convertible. 
 2.4 Exercise in Connection with an Initial Public Offering, Sale or Merger. Notwithstanding any other provision hereof, if the exercise of all or
any portion of this Warrant is made or to be made in connection with the occurrence of a public offering, sale or merger of the Company, the exercise of all or any portion of this Warrant shall, at the election of the Warrantholder, be conditioned
upon the consummation of the public offering, sale or merger of the Company in which case such exercise shall not be deemed to be effective until the consummation of such transaction. In the event that transaction is not consummated within 45 days
of the targeted date of the transaction, any such exercise shall, at the election of the Warrantholder, be deemed rescinded. 
 3. Stock
Fully Paid; Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant and Common Stock issuable upon conversion of the Preferred Stock will, upon issuance, be validly issued, fully paid and
non-assessable, issued in compliance with all applicable federal and state securities laws, and free from all taxes, liens and charges with respect to the issue thereof (except for any applicable transfer taxes which may arise from any subsequent
transfer of the Shares by Warrantholder, which shall be paid by Warrantholder). During the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved for the purpose of
issuance upon exercise of the purchase rights evidenced by this Warrant, a sufficient number of shares of its Preferred Stock (and Common Stock issuable upon conversion of the Preferred Stock) to provide for the exercise of the rights represented by
this Warrant. 
  

 4 

 4. Adjustment of Exercise Price and Number of Shares. The number of Shares purchasable upon the
exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a) Reclassification, Reorganization, Merger or Sale. In case of any (i) reclassification, reorganization, change or conversion of securities of the class issuable upon exercise of this Warrant (other than a change in par value,
or from par value to no par value, or from no par value to par value, or as a result of a subdivision, combination or stock dividend), or (ii) consolidation or merger of the Company with or into another corporation or entity (other than a
merger with another corporation or entity in which the Company is the surviving corporation and which does not result in any reclassification or change of outstanding securities issuable upon exercise of this Warrant), or (iii) sale of all or
substantially all of the assets of the Company, then in any of these events, the Company, or such successor or purchasing corporation, as the case may be, shall execute a new Warrant (in form and substance satisfactory to the holder of this Warrant)
providing that the holder of this Warrant shall have the right to exercise such new Warrant and upon such exercise to receive, in lieu of each share of Preferred Stock theretofore issuable upon exercise of this Warrant, the kind and amount of shares
of stock, other securities, money and property allocable to or receivable by a holder of one share of Preferred Stock upon such reclassification, change, consolidation, merger or sale. Such new Warrant shall provide for adjustments that shall be as
nearly equivalent as may be practicable to the adjustments provided for in this Section 4. The provisions of this section (a) shall similarly apply to successive reclassifications, changes, consolidations, mergers and sales. 
 (b) Subdivisions or Combination of Shares; Stock Dividends. In the event that the Company shall at any time subdivide the outstanding shares of
Preferred Stock, or shall issue a stock dividend on its outstanding shares of Preferred Stock, the number of Shares issuable upon exercise of this Warrant immediately prior to such subdivision or immediately prior to the issuance of such stock
dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased, and in the event that the Company shall at any time combine the outstanding shares of Preferred Stock, the number of Shares issuable upon
exercise of this Warrant immediately prior to such combination shall be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on the date of such subdivision, stock dividend or
combination, as the case may be. 
 (c) Issuance of Additional Shares. In the event that the Company shall issue shares of its capital
stock at a price less than the Exercise Price (after giving effect to any stock splits, reclassifications and the like) (a “Diluting Issuance “), the price at which the Shares may be converted into the Company’s Common Stock
shall be adjusted in accordance with the provisions of the Company’s then effective Certificate of Incorporation which apply to Diluting Issuances. The holder acknowledges that any adjustment to the conversion price arises from the provisions
of the Certificate of Incorporation, and that no additional right to adjustment based on the issuance of additional shares is created hereby. 
  

 5 

 (d) No Impairment. The Company will not, by amendment of its Amended and Restated Certificate of
Incorporation or through any reorganization, recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, seek to avoid the observance or performance of any of the terms to be
observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Section 4 and in the taking of all such action as may be necessary or appropriate in order to protect
the rights of the holder of this Warrant against impairment. 
 (e) Notices of Record Date. In case at any time: 
 (i) the Company shall declare any dividend upon its Preferred Stock or Common Stock payable in cash or stock or make any other distribution to the
holders of its Preferred Stock or its Common Stock; 
 (ii) the Company shall offer for subscription pro rata to the holders
of its Preferred Stock any additional shares of stock of any class, or other rights; 
 (iii) there shall be any capital reorganization or
reclassification of the capital stock of the Company, or a consolidation or merger of the Company with or into, or a sale of all or substantially all its assets to another entity or entities; or 
 (iv) there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company; 
 then, in any one or more of said cases, the Company shall give, by first class mail, postage prepaid, or by telex or telecopier, addressed to the holder of this Warrant
at the address of such holder as shown on the books of the Corporation, (A) at least 30 days’ prior written notice of the date on which the books of the Company shall close or a record shall be taken for such dividend, distribution or
subscription rights or for determining rights to vote in respect of any such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding up, and (B) in the case of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding up, at least 20 days’ prior written notice of the date when the same shall take place. Such notice in accordance with the foregoing clause (A) shall also
specify, in the case of any such dividend, distribution or subscription rights, the date on which the holders of Preferred Stock or Common Stock shall be entitled thereto, and such notice in accordance with the foregoing clause (B) shall also
specify the date on which the holders of Preferred Stock or Common Stock shall be entitled to exchange their Preferred Stock or Common Stock for securities or other property deliverable upon such reorganization, reclassification, consolidation,
merger, sale, dissolution, liquidation or winding up, as the case may be. 
 5. Notice of Adjustments. Whenever the Exercise Price
shall be adjusted pursuant to the provisions hereof, the Company shall within 20 days of such adjustment deliver a certificate 

  

 6 

 
signed on behalf of the Company by its chief financial officer (or an officer of similar standing) to the holder of this Warrant setting forth, in reasonable
detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price after giving effect to such adjustment. 
 6. Fractional Shares. No fractional shares of Preferred Stock or Common Stock will be issued in connection with any exercise hereunder, but in
lieu of such fractional shares the Company shall make a cash payment therefor upon the basis of the Exercise Price then in effect. 
 7.
Compliance with Securities Act; Disposition of Warrant or Shares of Preferred Stock; Compliance with Bank Holding Company Act. 
 (a)
Compliance with Securities Act. The holder of this Warrant, by acceptance hereof, agrees that this Warrant, the shares of Preferred Stock to be issued upon exercise hereof and the Common Stock to be issued upon the conversion of such
Preferred Stock are being acquired for investment purposes only and that such holder will not offer, sell or otherwise dispose of this Warrant or any shares of Preferred Stock to be issued upon exercise hereof (or Common Stock to be issued upon the
conversion of such Preferred Stock) except under circumstances which will not result in a violation of the Act and as permitted by Section 7(b) below. This Warrant and all shares of Preferred Stock issued upon exercise of this Warrant (or
Common Stock to be issued upon the conversion of such Preferred Stock) shall, unless registered under the Act, be stamped or imprinted with a legend in substantially the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO SALE OR DISPOSITION MAY BE EFFECTED WITH
OUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR (ii) AN OPINION OF COUNSEL FOR THE HOLDER, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED, EXCEPT THAT NO SUCH OPINION SHALL BE REQUIRED IF SUCH
SALE IS PURSUANT TO RULE 144 PROMULGATED UNDER THE ACT. A COPY OF THE AGREEMENT COVERING THE PURCHASE OR SALE OF THESE SECURITIES AND RESTRICTING THEIR TRANSFER OR SALE MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD
HEREOF. 
 (b) Disposition of Warrant and Shares. With respect to any offer, sale or other disposition of this Warrant or any
shares of Preferred Stock acquired pursuant to the exercise of this Warrant (or Common Stock to be issued upon the conversion of such Preferred Stock) prior to registration of such shares, the holder hereof and each subsequent holder of this Warrant
(or any shares of Preferred Stock or common stock issued upon conversion of the Preferred Stock) agrees to give written notice to the Company prior thereto, describing briefly the manner thereof, together with a written statement that he, she or it
is an “accredited investor” as defined under Rule 501 of Regulation D under the Act and agrees to be bound by all of the restrictions on transfer contained herein, along with a written opinion of such holder’s counsel, if reasonably

  

 7 

 
requested by the Company and reasonably satisfactory to the Company, to the effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect) of this Warrant or such shares of Preferred Stock (or Common Stock to be issued upon the conversion of such Preferred Stock) and indicating whether or not under the Act this Warrant or
the certificates representing such shares of Preferred Stock or Common Stock to be sold or otherwise disposed of require any restrictive legend thereon in order to ensure compliance with the Act. This Warrant or the certificates representing the
shares of Preferred Stock or Common Stock thus transferred (except a transfer pursuant to Rule 144) shall bear a legend as to the applicable restrictions on transferability in order to insure compliance with the Act, unless in the aforesaid opinion
of counsel for the holder, such legend is not required in order to insure compliance with the Act. If the legend is not required, Company agrees to reissue the Warrant and/or the shares receivable upon the exercise hereof without said legend.
Nothing herein shall restrict the transfer of this Warrant (or any portion hereof) or the certificates representing the shares of Preferred Stock acquired pursuant to the exercise of this Warrant (or Common Stock to be issued upon the conversion of
such Preferred Stock) by the initial holder hereof or any successor holder to (i) any affiliate of such holder, provided such affiliate is an accredited investor, including without limitation any partnership affiliated with such holder, any
partner of any such partnership or any successor corporation to the holder hereof as a result of a merger or consolidation with or a sale of all or substantially all of the stock or assets of the holder, (ii) any legal entity or natural person
(hereinafter “Person”) in a public offering pursuant to an effective registration statement under the Act, (iii) to any other Person to the extent that the transfer to such Person is exempt from the registration requirements of the
Act and such Person agrees in writing to be bound by all of the restrictions on transfer contained herein, or (iv) any Person or Persons if the holder hereof shall also transfer or assign all or part of its interest in the Financing Arrangement
and such Person agrees in writing to be bound by all of the restrictions on transfer contained herein. Any transfer described above must be made in compliance with all applicable federal and state securities laws. The Company may issue stop transfer
instructions to its transfer agent in connection with the foregoing restrictions. 
 8. Warrantholder’s Representations

 (a) The Warrantholder acknowledges that it has had access to all material information concerning the Company which it has requested. The
Warrantholder also acknowledges that it has had the opportunity to, and has to its satisfaction, questioned the officers of the Company with respect to its investment hereunder. The Warrantholder represents that it understands that the Warrant and
the Preferred Stock (and the shares of Common Stock issuable upon conversion of the Preferred Stock) are speculative investments, that it is aware of the Company’s business affairs and financial condition and that it has acquired sufficient
information about the Company to reach an informed and knowledgeable decision to acquire the Warrant. The Warrantholder is purchasing the Warrant and any Preferred Stock issued upon exercise thereof (and the shares of Common Stock issuable upon
conversion of the Preferred Stock) for investment for its own account only and not with a view to, or for resale in connection with, any “distribution” thereof in violation of the Act or applicable state securities laws. The Warrantholder
further represents that it understands that the Warrant and Preferred Stock have not 

  

 8 

 
been registered under the Securities Act or applicable state securities laws by reason of specific exemptions therefrom, which exemptions depend upon, among
other things, the bona fide nature of the Warrantholder’s investment intent as expressed herein. The Warrantholder acknowledges that it is experienced in evaluating and investing in companies engages in business similar to the Company’s
and that it has such knowledge and experience in financial and business affairs that it is capable of evaluating the merits and risks of investment in the Company and it is able to bear the economic risk of that investment. The Warrantholder is an
“accredited investor” as defined in Regulation D promulgated under the Securities Act. The Warrantholder’s corporate headquarters and principal place of business is located in the State of Illinois. 
 9. Company’s Representations 
 As
a material inducement to the Warrantholder to purchase this Warrant, the Company hereby represents and warrants that: 
 (a) The Company shall
have made all filings under applicable federal and state securities laws necessary to consummate the issuance of this Warrant pursuant to this Agreement in compliance with such laws, except for such filings as may be made properly after the Closing.

 (b) If applicable, the Company, the Warrantholder and any original investors in the Company who are parties to any stock purchase
agreements, and whose consent or approval is required prior to the execution and delivery of this Warrant, shall have entered into an amendment to each such stock purchase agreement to provide for such consent and any required waivers, in such form
and substance acceptable to the Warrantholder, and such amendment shall be in full force and effect as of the date hereof. 
 (c) If
applicable, the Company, the Warrantholder and any original holders of shares in the Company who are parties to any investor’s rights agreements, and whose consent or approval is required prior to the execution and delivery of this Warrant,
shall have entered into an amendment to each such investor’s rights agreement, providing for such consent and any required waivers and, where appropriate, adding the Warrantholder as a party thereto, in such form and substance acceptable to the
Warrantholder, and such amendment shall be in full force and effect as of the date hereof. 
 (d) The copies of any existing stock purchase
agreements and investor’s rights agreements and the Company’s charter documents and bylaws which have been furnished to Warrantholder or the Warrantholder’s counsel reflect all amendments made thereto at any time prior to the date
hereof and are correct and complete. 
 (e) As of the date hereof, the authorized capital stock of the Company shall be as stated on the
Capitalization Schedule attached hereto as Exhibit B (the “Capitalization Schedule”) and made a part hereof. As of the date hereof, except for this Warrant and except as set forth on the attached Capitalization Schedule, the
Company shall not have outstanding any stock or 

  

 9 

 
securities convertible or exchangeable for any shares of its capital stock or containing any profit participation features, nor shall it have outstanding any
rights, warrants or options to subscribe for or to purchase its capital stock or any stock or securities convertible into or exchangeable for its capital stock or any stock appreciation rights or phantom stock plans. The Capitalization Schedule
truthfully and accurately sets forth the Company’s information with respect to all outstanding options and rights to acquire the Company’s capital stock. As of the date hereof, except as set forth on the Capitalization Schedule, the
Company shall not be subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of its capital stock or any warrants, options or other rights to acquire its capital stock. As of the date hereof, all
of the outstanding shares of the Company’s capital stock shall be validly issued, fully paid and nonassessable. 
 (f) With respect to
the issuance of this Warrant or the issuance of the Preferred Stock upon exercise of the Warrant (and the shares of Common Stock issuable upon conversion of the Preferred Stock), there are no statutory or contractual stockholders preemptive rights
or rights of refusal, except for any such rights contained in any stock purchase agreement and/or investor’s rights agreements which have been waived. The Company has not violated any applicable federal or state securities laws in connection
with the offer, sale or issuance of any of its capital stock, and the offer, sale and issuance of this Warrant does not require registration under the Securities Act or any applicable state securities laws. To the best of the Company’s
knowledge, there are no agreements between the Company’s stockholders with respect to the voting or transfer of the Company’s capital stock or with respect to any other aspect of the Company’s affairs, except for any stock purchase
agreements and any investor’s rights agreements identified on the attached Capitalization Schedule. 
 (g) The execution, delivery and
performance of this Warrant has been duly authorized by the Company. This Warrant constitutes a valid and binding obligation of the Company, enforceable in accordance with its respective terms. The execution and delivery by the Company of this
Warrant, the issuance of the Preferred Stock upon exercise of this Warrant (and the shares of Common Stock issuable upon conversion of the Preferred Stock), and the fulfillment of and compliance with the respective terms hereof and thereof by the
Company, do not and shall not (i) conflict with or result in a breach of the terms, conditions or provisions of, (ii) constitute a default under, (iii) result in the creation of any lien, security interest, charge or encumbrance upon
the Company’s capital stock or assets pursuant to, (iv) give any third party the right to modify, terminate or accelerate any obligation under, (v) result in a violation of, or (vi) require any authorization, consent, approval,
exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to, the charter or bylaws of the Company or any subsidiary, or any law, statute, rule or regulation to
which the Company or any subsidiary is subject, or any agreement, instrument, order, judgment or decree to which the Company or any subsidiary is subject, except for any such filings required under applicable “blue sky” or state securities
laws or required under Regulation D promulgated under the Securities Act. 
  

 10 

 10. Company’s Covenants 
 (a) Until such time as the Company shall have satisfied all of its obligations under the Financing Arrangement, Company shall deliver to Warrantholder
such financial information as is required under the terms of the Financing Arrangement. From and after the date that the Company shall have satisfied all of its obligations under the Financing Arrangement, the Company shall deliver to the
Warrantholder (so long as the Warrantholder holds all or any portion of the Warrant or any Preferred Stock or any shares of Common Stock issuable upon conversion of the Preferred Stock) all of the financial and other information delivered or
required to be delivered by the Company to any of its stockholders. All such financial and other information shall be delivered pursuant to this Section 10(a) on a timely basis, but no later than 30 days after each fiscal quarter end for
quarterly statements and no later than 90 days after each fiscal year end for annual statements. 
 11. Miscellaneous 
 (a) Rights as Shareholders. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder of Preferred
Stock (or Common Stock to be issued upon the conversion of such Preferred Stock) or otherwise be entitled to any voting or other rights as a shareholder of the Company, until this Warrant shall have been exercised and the Shares purchasable upon the
exercise shall have become deliverable, as provided herein. 
 (b) Issuance Tax. The issuance of certificates for shares of Preferred
Stock upon exercise of this Warrant (or Common Stock to be issued upon the conversion of such Preferred Stock) shall be made without charge to the holder hereof for any issuance tax in respect hereof, provided that the Company shall not be required
to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than that of the holder of this Warrant. 
 (c) No Inconsistent Agreements. The Company shall not hereafter enter into any agreement with respect to its securities which is inconsistent with
or violates the rights granted to the holders of Registrable Securities by the Company whether hereunder or in any other document, agreement or instrument by which the Company may be bound. For the purposes of this Agreement, “Registrable
Securities” means (i) any Preferred Stock issued upon exercise of this Warrant (and the shares of Common Stock issuable upon conversion of the Preferred Stock) and (ii) any Preferred or Common Stock issued or issuable with respect to
the securities referred to in clause (i) above by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, sale, consolidation or other reorganization. For purposes hereof, a Person shall
be deemed to be a holder of Registrable Securities, and the Registrable Securities shall be deemed to be in existence, whenever such Person has the right to acquire directly or indirectly such Registrable Securities (upon conversion or exercise in
connection with a transfer of securities or otherwise, but disregarding any restrictions or limitations upon the exercise of such right), whether or not such acquisition has actually been effected, and such Person shall be entitled to exercise the
rights of a holder of Registrable Securities hereunder. 
  

 11 

 (d) Modification and Waiver. This Warrant and any provision hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the Company and the holder of this Warrant. 
 (e) Attorneys’
Fees. In the event of an action, suit or proceeding brought under or in connection herewith, the prevailing party therein shall be entitled to recover from, and the other party hereto agrees to pay, the prevailing party’s costs and expenses
in connection therewith, including reasonably attorneys’ fees. 
 (f) Notices. All notices, demands or other communications
required or permitted to be given or delivered under or by reason of the provisions hereof shall be in writing and shall be deemed to have been given when delivered personally to the recipient, the next business day after having been sent to the
recipient by reputable overnight courier service (charges prepaid) or four business days after having been mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid. Such notices, demands and other
communications shall be sent to the Warrantholder and to the Company at the respective addresses indicated on the signature page hereof, or to such other address or to the attention of such other person as the recipient party has specified by prior
written notice to the sending party. 
 (g) Binding Effect on Successors. This Warrant shall be binding upon any corporation
succeeding the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets, and all of the obligations of the Company relating to the Preferred Stock issuable upon the exercise of this Warrant (or Common
Stock to be issued upon the conversion of such Preferred Stock) shall survive the exercise and termination of this Warrant and all of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the holder
hereof. All covenants and agreements contained herein by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not. In addition, whether
or not any express assignment has been made, the provisions hereof which are for the benefit of Warrantholders or holders of Registrable Securities are also for the benefit of, and enforceable by, any subsequent holder of Registrable Securities. The
Company will, at the time of the exercise of this Warrant, in whole or in part, upon request of the holder hereof but at the Company’s expense, acknowledge in writing its continuing obligation to the holder hereof in respect of any rights
(including, without limitation, any right to registration of the Shares which rights are agreed to by the Company) to which the holder hereof shall continue to be entitled after such exercise in accordance with this Warrant; provided that the
failure of the holder hereof to make any such request shall not affect the continuing obligation of the Company to the holder hereof in respect of such rights. 
 (h) Lost Warrants or Stock Certificates. The Company covenants to the holder hereof that upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this
Warrant or any stock certificate issued upon exercise hereof or in replacement thereafter and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company and without requiring any bond, or
in the case of any such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company will make and deliver a new Warrant or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant
or stock certificate. 
  

 12 

 (i) Registration Rights. The holder hereof shall be entitled, upon execution of an amendment to
the Company’s Amended and Restated Investors’ Rights Agreement, dated as of July 20, 2001, September 5, 2001 and September 18, 2001, attached hereto as Exhibit C (the “Rights Agreement”), with respect
to the shares of Preferred Stock issued upon exercise hereof or the shares of Common Stock issued upon conversion of the Preferred Stock, to the piggyback registration rights set forth in Section 2.3 of the Rights Agreement to the same extent
and on the same terms and conditions as possessed by the Investors thereunder. 
 (j) Market Stand-Off. To the extent requested by the
Company and an underwriter of Common Stock or other securities of the Company, Warrantholder hereby agrees that during the period of duration (not to exceed 180 days) specified by the Company and such underwriter following the effective date of any
registered underwritten public offering of Company securities (the “Stand Off Period”), it shall not directly or indirectly sell, offer to sell, contract to sell (including, without limitation, any short sale), grant any option to purchase
or otherwise transfer or dispose of any securities of the Company held by it at any time during such period, except Common Stock included in such registration; provided, however, that this agreement on restrictions shall be void and of
no force and effect unless similar restrictions upon transfer are entered into by the Company’s executive officers and directors, including but not limited to the term of duration of the Stand Off Period. In order to enforce this covenant, the
Company may impose stop-transfer instructions with respect to the Company’s securities held by such holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. 
 (k) Descriptive Headings. The descriptive headings of the several paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant. 
 (l) Governing Law. THIS WARRANT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE
RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAWS OF THE STATE OF CALIFORNIA, EXCLUDING THAT BODY OF LAW RELATING TO CONFLICTS OF LAW AND CHOICE OF LAW. 
 SIGNATURE PAGE FOLLOWS: 
  

 13 

 In Witness Whereof, this Warrant to purchase Preferred Stock has been duly executed as of the Grant Date hereinabove
set forth. 
  

									
	Issued By:	 		 	Accepted By:
			
	Danger, Inc.	 		 	Heller Financial Leasing, Inc.
					
	By:	 	 /s/ Andrew E. Rubin
	 		 	By:	 	 /s/ Charles Arkin

	Title:	 	CEO	 		 	Title:	 	AVP – Contract Administration
			
	Address for Notices:	 		 	Address for Notices:
	124 University Ave.	 		 	500 West Monroe
	Palo Alto, CA 94301	 		 	Chicago, IL 60661
		 		 	Attention: Portfolio Management,

 Dated as of : 1/25/02 
 Copy to: 
 Brobeck, Phleger & Harrison 
 Two Embarcadero Place 
 2200 Gerg Road 
 Palo Alto, CA 94303 
 Atten: David Makarechian, Esq. 
  

 14 

 EXHIBIT A 
 Notice of Exercise 
  

	To:	Danger, Inc. (“Company”) 

 124
University Ave. 
 Palo Alto, CA 94301 
 Attention: Chief Financial Officer 
 [1. The undersigned hereby elects to purchase
                                        
shares of Series B-1 Preferred Stock of Company pursuant to the terms of the attached Warrants, and tenders herewith payment of the purchase price of such shares in full.] 
 [1. The undersigned hereby elects to purchase
                                     shares of Series B-1
Preferred Stock of Company pursuant to a non-cash exercise of the Warrant as provided in Section 2.2 of the Warrant. *] 
 2. Check here
if applicable:          The undersigned confirms that this exercise is made in connection with the occurrence of a public offering, sale or merger of the Company, and the undersigned further elects to
condition this exercise of the Warrant upon the consummation of said public offering, sale or merger of the Company. This exercise shall not be deemed to be effective until the consummation of such transaction. In the event that transaction is not
consummated within 45 days of the targeted date of the transaction, the undersigned will advise Company whether or not this exercise should be deemed rescinded. 
 2. Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name or names as are specified below: 
 Heller Financial Leasing, Inc. 
 500 West Monroe 
 Chicago, IL 60661 
 3. The undersigned represents that the aforesaid shares are being acquired for the account of the undersigned for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing such shares. 
  

			
	Heller Financial Leasing, Inc.
		
	By:	 	  

		 	(Signature)
		
	Its:	 	  

		
	Date:	 	  

  

 15Form of Series D Preferred Stock Warrant of the Registrant

 Exhibit 4.5 
 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACT. 
 Warrant No. «Warrant_No» 
 DANGER, INC. 
 WARRANT TO PURCHASE SHARES OF SERIES D PREFERRED STOCK 
 This Warrant is issued to «Name_of_Investors» (“Holder”) by Danger, Inc., a Delaware corporation (the “Company”), as of
January 27, 2003. 
 1. Purchase of Shares. Subject to the terms and conditions hereinafter set forth herein, Holder is entitled,
upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify Holder in writing), to purchase from the Company up to «Warrant_Written» («Warrant») shares (the
“Shares”) of Series D Preferred Stock of the Company (the “Series D Preferred Stock”) at an exercise price of $0.9007 per share (the “Exercise Price”). The Shares and the Exercise Price shall be subject to adjustment as
set forth in Section 8 hereof. 
 2. Exercise Period. This Warrant shall be exercisable for a period (the “Exercise
Period”) of seven (7) years from the date hereof; provided, however, that in the event of the earlier closing of (a) the issuance and sale of shares of the Company’s Common Stock (the “Common Stock”) in
the Company’s first underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Act”), at a per share price to the public that values the Company at not less than
$373 million and in which the aggregate proceeds to the Company (before deduction of underwriters’ discounts and expenses relating to the issuance, including, without limitation, fees of the Company’s counsel) are at least $35,000,000,
(b) a sale of all or substantially all the assets of the Company, or (c) a merger or reorganization of the Company into or consolidation with any other entity (excluding a reorganization or merger, the sole purpose of which is to change
the jurisdiction of incorporation of the Company), this Warrant shall, on the date of such event, no longer be exercisable and become null and void. In the event of a proposed transaction of the kind described above, the Company shall notify Holder
in writing at least fifteen (15) days prior to the consummation of such event or transaction. 
 3. Method of
Exercise. While this Warrant remains outstanding and exercisable during the Exercise Period, Holder may exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: (i) the surrender of the
Warrant, together with a duly executed copy of the form of Exercise Notice attached hereto, to the Chief Executive Officer of the Company at its principal offices; and (ii) the payment to the Company 

 
by cash, check or wire transfer of an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 
 4. Effective Time of Exercise. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on
the day on which this Warrant shall have been surrendered to the Company as provided in Section 3 above. At such time, the person or persons in whose name or names any certificates for Series D Preferred Stock shall be issuable upon such
exercise as provided in Section 6 below shall be deemed to have become the holder or holders of record of the Series D Preferred Stock represented by such certificates. 
 5. Net Issuance Provision. In lieu of exercising pursuant to paragraph 3 above, at the Holder’s option, while this Warrant remains
outstanding and exercisable during the Exercise Period, Holder may exercise this Warrant by surrender of this Warrant as determined below (“Net Issuance”). If the Holder elects the Net Issuance method, the Company will issue Series D
Preferred Stock in accordance with the following formula: 
 X = Y(A-B) 
             A 
 Where: 
  

	 	X =	the number of shares of Series D Preferred Stock to be issued to the Holder. 

  

	 	Y =	the number of shares of Series D Preferred Stock requested to be exercised under this Warrant Agreement. 

  

	 	A =	the fair market value of one (1) share of Series D Preferred Stock. 

  

	 	B =	the Exercise Price (as adjusted on the date of calculation). 

 For purposes of the above calculation, current fair market value of Series D Preferred Stock shall mean with respect to each share of Series D Preferred Stock: 
 (a) the product of (i) the average daily Market Price (as defined below) during the period of the most recent ten (10) days, ending on the last
business day before the effective date of exercise, on which the national securities exchanges were open for trading and (ii) the number of shares of the Common Stock (as defined herein) into which each share of Series D Preferred Stock is
convertible on such date; or 
 (b) if no class of Common Stock is then listed or admitted to trading on any national securities exchange or
quoted in the over-counter market, the fair market value shall be the Market Price (as defined in Section 5(c) hereof) on the last business day before the effective date of exercise. 
 (c) If the Common Stock is traded on a national securities exchange or admitted to unlisted trading privileges on such an exchange, or is listed on the
National Market 

  

 2 

 
System (the “National Market System”) of the Nasdaq, the Market Price as of a specified day shall be the last reported sale price of Common Stock
on such exchange or on the National Market System on such date or if no such sale is made on such day, the mean of the closing bid and asked prices for such day on such exchange or on the National Market System. If the Common Stock is not so listed
or admitted to unlisted trading privileges, the Market Price as of a specified day shall be the mean of the last bid and asked prices reported on such date (x) by the Nasdaq or (y) if reports are unavailable under clause (x) above by
the National Quotation Bureau Incorporated. If the Common Stock is not so listed or admitted to unlisted trading privileges and bid and ask prices are not reported, the Market Price as of a specified day shall be determined in good faith by the
Board of Directors of the Company. 
 Upon partial exercise by either cash or Net Issuance, the Company shall promptly issue an amended
Warrant representing the remaining number of shares purchasable thereunder. All other terms and conditions of such amended Warrant shall be identical to those contained herein, including, but not limited to, the Exercise Period. 
 6. Certificates for Shares. Upon the exercise of the purchase rights evidenced by this Warrant, one or more certificates for the number of
Shares so purchased shall be issued as soon as practicable thereafter. Upon any partial exercise of this Warrant, the Company will forthwith issue and deliver to Holder a new warrant or warrants of like tenor as this Warrant for the remaining
portion of the Series D Preferred Stock for which this Warrant may still be exercised. The Company shall pay all expenses, and any and all stamp or similar taxes (but excluding transfer taxes) that may be payable in connection with the preparation,
issuance and delivery of stock certificates and any new warrant certificate under this Section 6. 
 7. Issuance of
Shares. The Company covenants that (a) the Shares, when issued pursuant to the exercise of this Warrant, will be duly and validly issued, fully-paid and non-assessable and free from all taxes, liens and charges with respect to the
issuance thereof (except for any applicable transfer taxes, which shall be paid by Holder) and (b) during the Exercise Period, the Company will reserve from its authorized and unissued Series D Preferred Stock a sufficient number of shares to
provide for the issuance of Series D Preferred Stock upon the exercise of this Warrant. 
 8. Adjustment of Exercise Price and Number of
Shares. The number of and kind of securities purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a) Subdivisions, Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide its Series
D Preferred Stock, by split or otherwise, or combine its Series D Preferred Stock, or issue additional shares of its Series D Preferred Stock as a dividend with respect to any shares of its Series D Preferred Stock, the number of Shares issuable on
the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the purchase price
payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 8(a) shall become effective as of the record date
of such subdivision, combination or dividend, or in the 

  

 3 

 
event that no record date is fixed, upon the making of such subdivision, combination or dividend. It being understood that the Series D Preferred Stock
issuable upon exercise of the Warrant shall be subject to the provisions set forth in the Amended and Restated Certificate of Incorporation as in effect as of the date hereof (the “Restated Certificate”) which relate to the adjustment of
the Conversion Price, as that term is defined in the Restated Certificate. 
 (b) Reclassification, Reorganization and Consolidation.
In case of any reclassification, capital reorganization, or change in the Series D Preferred Stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 8(a) above), then, as a condition
of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to Holder, so that Holder shall have the right at any time prior
to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such reclassification,
reorganization or change by a holder of the same number of shares of Series D Preferred Stock as were purchasable by Holder immediately prior to such reclassification, reorganization or change. In any such case, appropriate provisions shall be made
with respect to the rights and interest of Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments shall
be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same. 
 (c)
Conversion. If all of the Company’s outstanding Preferred Stock is redeemed or converted into shares of Common Stock, then this Warrant shall automatically become exercisable for that number of shares of Common Stock that would have been
received if this Warrant had been exercised in full and the shares of Series D Preferred Stock received thereupon had been simultaneously converted into shares of Common Stock, in each case immediately prior to such redemption or conversion.
Appropriate provisions shall be made with respect to the rights and interests of Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of Common Stock deliverable upon exercise hereof, and appropriate
adjustments shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of shares of Common Stock purchaseable under this Warrant (as adjusted) shall remain the same. 
 (d) Certificate of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant or in the Exercise Price, an officer of the Company shall promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth, in reasonable detail, the event requiring the adjustment, the
amount of the adjustment, the method by which such adjustment was calculated and the Exercise Price and number of shares purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first
class mail, postage prepaid) to Holder. 
  

 4 

 9. Compliance with Securities Laws. Holder hereby represents and warrants that: 

(a) Purchase Entirely for Own Account. This Warrant and the Series D Preferred Stock issuable upon exercise hereof (collectively, the
“Securities”) will be acquired for investment for Holder’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and Holder has no present intention of selling, granting any
participation in or otherwise distributing the same. Holder does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to any person with respect to any of the Securities. Holder
represents that it has full power and authority to enter into this Warrant. 
 (b) Investment Experience. Holder acknowledges
that it is able to fend for itself, can bear the economic risk of its investment and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in this Warrant. Holder
also represents it has not been organized for the purpose of acquiring this Warrant. 
 (c) Accredited Investor. Holder is an
“accredited investor” within the meaning of Rule 501 of Regulation D of the Securities and Exchange Commission (the “SEC”), as presently in effect. 
 (d) Restricted Securities. Holder understands that the Securities are characterized as “restricted securities” under the federal
securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering, and that under such laws and applicable regulations such securities may be resold without registration under the Act only in
certain limited circumstances. In this connection, Holder represents that it is familiar with SEC Rule 144 promulgated under the Act, as presently in effect, and understands the resale limitations imposed thereby and by the Act. 
 10. Further Limitations on Disposition. Without in any way limiting the representations set forth above, Holder further agrees not to make
any disposition of all or any portion of the Securities unless and until there is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance with such registration statement,
or (i) Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (ii) if reasonably requested by the
Company, Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Act. 
 11. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the fair market value of the Company’s Series D Preferred Stock as determined pursuant to Section 5 above. 
 12. No Stockholder Rights. Prior to exercise of this Warrant, Holder shall not be entitled to any rights of a stockholder with respect to the
Shares, including (without 

  

 5 

 
limitation) the right to vote such Shares, receive dividends or other distributions thereon, exercise preemptive rights or be notified of stockholder
meetings, and Holder, as such, shall not be entitled to any notice or other communication concerning the business or affairs of the Company, except as set forth in Section 2 above. 
 13. Replacement of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company
at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 
 14. Notices. All
notices or other communications hereunder shall be in writing and shall be deemed given when (i) personally delivered, (ii) three days after being sent by prepaid certified or registered U.S. mail, or one day after being sent, if sent by
nationally recognized overnight courier, to the address of the party to be noticed as set forth herein or such other address as such party last provided to the other by written notice, or (iii) upon receipt of electronic confirmation, if by
facsimile. All notices shall be sent to the addresses and facsimile numbers set forth below or such other address as may be given from time to time under the terms of this notice provision: 
 If to the Company: 
 Danger, Inc.

 124 University Ave. 
 Palo
Alto, CA 94301 
 Attention: Chief Executive Officer 
 If to Holder: 
 At the address and facsimile number 
 previously indicated to the Company. 
 15.
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Warrant shall inure to the benefit of and be binding upon the successors and assigns of the parties (including transferees of any Shares).
Nothing in this Warrant, express or implied, is intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any rights, remedies, obligations or liabilities under or by reason of this Warrant, except
as expressly provided herein. The Warrant and Shares shall not be transferable by Holder except to an affiliate of such Holder, including, without limitation, any affiliated corporation, partnership, limited partnership, limited liability company,
or an investment fund, or to any stockholders, partners, general partners, limited partners and members of such Holder, provided that such affiliate, stockholder, partner, general partner, limited partner or member agrees in writing to be subject to
the obligations and conditions set forth herein. 
 16. Amendments and Waivers. Any term of this Warrant may be amended and the
observance of any term of this Warrant may be waived (either generally or in a particular 

  

 6 

 
instance and either retroactively or prospectively), with the written consent of each of the parties hereto. Any waiver or amendment effected in accordance
with this section shall be binding upon Holder and the Company. 
 17. Governing Law. This Warrant shall be governed by the laws
of the State of California as applied to agreements among California residents made and to be performed entirely within the State of California. Each of the parties irrevocably and unconditionally waives, to the fullest extent permitted by law, any
and all rights to a trial by jury in connection with any litigation arising out of or relating to this Warrant or the transaction contemplated hereby. 
 18. Market Stand-off Provision. Holder hereby agrees that, during the period of duration not to exceed 180 days specified by the Company and an underwriter of Common Stock or other securities of the
Company, following the effective date of the first registration statement for a firm commitment underwritten public offering of the Company’s securities filed under the Act, and, for a period of duration not to exceed 90 days specified by the
Company and an underwriter of Common Stock or other securities of the Company, following the effective date of any subsequent registration statement for a firm commitment underwritten public offering of the Company’s securities filed under the
Act, it shall not, to the extent requested by the Company and such underwriter, directly or indirectly, sell, offer to sell, contract to sell (including, without limitation, any short sale), grant any option to purchase or otherwise transfer or
dispose of (other than to donees who agree to be similarly bound), or reduce its interest in (collectively, “Transfer”), any Shares issuable upon exercise of this Warrant during such period except Common Stock included in such
registration; provided, however, that all executive officers, directors and stockholders that hold one percent (1%) or more of the Common Stock (including on an as-converted basis any shares of Common Stock issuable upon the
conversion or exercise of any share of the Company’s Preferred Stock, warrant, right or other security) of the Company enter into similar agreements. Such restrictions, however, shall not be applicable to transfers to any affiliated entity of
Holder, including any affiliated corporation, partnership, limited partnership, limited liability company or investment fund, or to any stockholders, partners, general partners, limited partners and members of Holder, in each case who agree in
writing to be bound by this Warrant, including this Section 18. 
 To enforce the foregoing covenant, the Company may impose
stop-transfer instructions with respect to the Company’s securities held by Holder (and the shares or securities of every other person or entity subject to the foregoing restriction) until the end of such period. 
 19. Entire Agreement. This Warrant and the other documents delivered pursuant hereto or referred to herein, constitute the full and entire
understanding and agreement between the parties with regard to the subjects hereof. 
 20. Severability. In case any provision of this
Warrant shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
  

 7 

 21. Counterparts. This Warrant may be executed in any number of counterparts, each of which shall
be an original, but all of which together shall constitute one instrument. 
 22. Survival. Except as expressly set forth herein, the
representations, warranties, covenants and agreements made herein shall survive the closing of the transactions contemplated hereby. 
 23.
Confidentiality. Holder agrees that, except with the prior written consent of the Company, Holder shall at all times keep confidential and not divulge, furnish or make accessible to anyone any confidential information, knowledge or data
concerning or relating to the business or financial affairs of the Company to which Holder has been or shall become privy. The provisions of this Section 23 shall be in addition to, and not in substitution for, the provisions of any separate
nondisclosure agreement executed by the parties hereto. 
  

 8 

 IN WITNESS WHEREOF, this Warrant is executed as of the date first referenced above. 
  

			
	COMPANY:
	
	DANGER, INC.
		
	By:	 	  

		 	Henry R. Nothhaft, Chairman and Chief Executive Officer

 EXERCISE NOTICE 
 Danger, Inc. 
 Attention: Chief Executive Officer 
 1. The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant to Purchase Shares of Series D Preferred Stock issued by Danger,
Inc. and held by the undersigned, the original of which is attached hereto,
                                 shares of Series D Preferred Stock of Danger,
Inc. Payment of the exercise price per share required under such Warrant accompanies this Exercise Notice. 
 2. The undersigned hereby
represents and warrants that the undersigned is acquiring such shares for its own account for investment purposes only, and not for resale or with a view to distribution of such shares or any part thereof. 
  

					
	 HOLDER:

	
	  

	 Name:
	 		 	
	 Title:
	 		 	
			
	 Date:
	 	  
	 	
	
	 Address:

	  

	  

	
	 Name in which shares should be registered:

	
	  

  

 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]